Topics discussed in this podcast include the rise in labor strikes in the US, flaws in the negotiation process, the potential of Miami as a tech hub, and advancements in AI for biology and healthcare.
Miami's tech boom is fueled by its affordability, access to capital, and Latin American connections.
AI's breakthrough in predicting protein structures aids in diagnosing rare genetic diseases and developing drugs.
Deep dives
The Rise of VC Investment in Miami
VC investment in South Florida quadrupled during the pandemic, with market share in terms of number of deals holding steady. Miami offers a more affordable cost of living compared to West Coast cities, deep pockets of capital, and a strong connection to Latin America, making it an attractive location for early-stage startups.
AI's Ability to Predict Protein Structures
Using AI, scientists have successfully predicted the 3D structures of proteins, transforming the way drugs are developed and diseases are understood. Google's DeepMind created alpha fold, a program that accurately predicts protein structures for over 214 million proteins. This breakthrough helps in unveiling which genetic mutations are harmful, aiding doctors in diagnosing rare genetic diseases.
The Potential of AI in Healthcare
While concerns around patient privacy and overreliance on AI exist in healthcare, AI has shown promise in drug discovery, diagnosis, and predicting protein interactions. DeepMind's advancements in predicting protein structures and identifying harmful mutations demonstrate the potential for AI to complement doctors' expertise in healthcare settings.
Challenges of AI in Healthcare
Some challenges of implementing AI in healthcare include patient privacy concerns and the risk of relying solely on AI without considering doctors' experience and intuition. However, when integrated properly with other medical information, AI has the potential to greatly enhance disease diagnosis and treatment.
We discuss the state of labor in the US, the outlook for the GOP and Democrats, Miami's potential tech boom, and genetics and AI. Columnists Betsey Stevenson, Jonathan Bernstein, Lisa Jarvis, and Jonathan Levin join. Amy Morris hosts.